"Abridge Secures $150M Series C for Advancing AI Clinical Documentation Tools"
TL;DR Summary
Abridge, a startup specializing in AI medical scribing, has raised $150 million in a Series C funding round led by Lightspeed and Redpoint Ventures, bringing its post-money valuation to $850 million. The company aims to enhance its AI technology to create more useful medical notes, improve clinical documentation, and compete with industry giants like Nuance in the electronic health records space. The funding will support Abridge's expansion into more hospitals and further research and development efforts.
- Abridge Raises $150 Million To Make AI Medical Scribes Even Smarter Forbes
- Lightspeed, CVS back Abridge's $150M round for generative AI FierceHealthcare
- 'We've met the moment': A Lawrenceville startup using generative AI to help doctors gets funding boost Pittsburgh Post-Gazette
- Nuance competitor Abridge closes $150M Series C Modern Healthcare
- Abridge raises $150M Series C in race for AI clinical documentation tools Axios
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
3 min
vs 4 min read
Condensed
90%
734 → 76 words
Want the full story? Read the original article
Read on Forbes